<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">tumors</journal-id><journal-title-group><journal-title xml:lang="ru">Malignant tumours</journal-title><trans-title-group xml:lang="en"><trans-title>Malignant tumours</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2224-5057</issn><issn pub-type="epub">2587-6813</issn><publisher><publisher-name>Rosoncoweb</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18027/2224-5057-2021-11-3s2-25</article-id><article-id custom-type="elpub" pub-id-type="custom">tumors-873</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GUIDELINES</subject></subj-group></article-categories><title-group><article-title>Практические рекомендации по лекарственному лечению больных гепатоцеллюлярным раком</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бредер</surname><given-names>В. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балахнин</surname><given-names>П. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Санкт-Петербург</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Виршке</surname><given-names>Э. Р.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косырев</surname><given-names>В. Ю.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ледин</surname><given-names>Е. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петкау</surname><given-names>В. В.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатеринбург </p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава России</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ГБУЗ «Санкт-Петербургский клинический научно-практический центр специализированных видов медицинской помощи (онкологический)»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>Клиническая больница Медси</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-4"><institution>ООО «Европейский медицинский центр «УГМК-Здоровье»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>07</day><month>11</month><year>2021</year></pub-date><volume>11</volume><issue>3s2-1</issue><fpage>431</fpage><lpage>451</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бредер В.В., Балахнин П.В., Виршке Э.Р., Косырев В.Ю., Ледин Е.В., Петкау В.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Бредер В.В., Балахнин П.В., Виршке Э.Р., Косырев В.Ю., Ледин Е.В., Петкау В.В.</copyright-holder><copyright-holder xml:lang="en">Бредер В.В., Балахнин П.В., Виршке Э.Р., Косырев В.Ю., Ледин Е.В., Петкау В.В.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.malignanttumors.org/jour/article/view/873">https://www.malignanttumors.org/jour/article/view/873</self-uri><abstract><p>.</p></abstract><kwd-group xml:lang="ru"><kwd>гепатоцеллюлярный рак</kwd><kwd>фиброламеллярная карцинома</kwd><kwd>цирроз печени</kwd><kwd>BCLC</kwd><kwd>ТАХЭ</kwd><kwd>РЧА</kwd><kwd>аблация</kwd><kwd>иммунотерапия</kwd><kwd>атезолизумаб</kwd><kwd>бевацизумаб</kwd><kwd>сорафениб</kwd><kwd>регорафениб</kwd><kwd>ленватиниб</kwd><kwd>кабозантиниб</kwd><kwd>рамуцирумаб</kwd><kwd>ниволумаб</kwd><kwd>ипилимумаб</kwd><kwd>гепатит С</kwd><kwd>гепатит B</kwd><kwd>HCV</kwd><kwd>HBV</kwd><kwd>АФП</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
